Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Merck & Co. Inc. acquires Sibia Neurosciences

Executive Summary

In an effort to strengthen its CNS drug discovery research capability, Merck & Co. Inc. will acquire Sibia Neurosciences Inc. for $8.50 per share, a (pr)68% premium based on the 10-day trailing average price of $5.06. The transaction is valued at about $87mm, and is expected to close this September.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition

Related Companies